Serpentine supravenous hyperpigmentation in association with anti-TIF1-gamma antibody-positive myositis

被引:0
|
作者
Richardson, William M. [1 ]
Zampella, John G. [1 ]
Meehan, Shane A.
Femia, Alisa N. [1 ]
机构
[1] NYU Langone Hlth, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA
关键词
inflammatory myopathies; TIF1-gamma autoantibodies; serpentine supravenous hyperpigmentation; COVID-19; vaccination; SARS-CoV-2; skin of color (SOC);
D O I
10.1111/ijd.17391
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Serum biomarkers of interstitial lung disease in jo-1 antibody-positive myositis
    Eggebeen, A.
    Rosas, I.
    Kaminski, N.
    Richards, T.
    Oddis, C.
    Ascherman, D.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4259 - 4259
  • [42] Anti-mitochondrial M2 antibody-positive myositis mimicking amyotrophic lateral sclerosis
    Kudo, Takuya
    Hayashi, Yuichi
    Yaguchi, Tomonori
    Kunieda, Kenjiro
    Higashida, Kazuhiro
    Yamada, Megumi
    Kimura, Akio
    Shimohata, Takayoshi
    NEUROLOGY, 2021, 96 (15)
  • [43] Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population
    Abhilasha Manwatkar
    Shivraj Padiyar
    Aswin Nair
    Avanish Jha
    Sathish Kumar
    Bijesh Yadav
    John Antony Jude Prakash
    John Kumar Das
    John Mathew
    Clinical Rheumatology, 2023, 42 : 3289 - 3297
  • [44] Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population
    Manwatkar, Abhilasha
    Padiyar, Shivraj
    Nair, Aswin
    Jha, Avanish
    Kumar, Sathish
    Yadav, Bijesh
    Prakash, John Antony Jude
    Das, John Kumar
    Mathew, John
    CLINICAL RHEUMATOLOGY, 2023, 42 (12) : 3289 - 3297
  • [45] Favourable complete remission of anti-OJ antibody-positive myositis after lung cancer resection
    Shibata, Makoto
    Makioka, Kouki
    Hamaguchi, Yasuhito
    Ikeda, Yoshio
    RHEUMATOLOGY, 2022, 61 (03) : E77 - E79
  • [46] Case Report: IVIG causing bilateral papilledema and increased intracranial hypertension in patients with anti-TIF-1γ antibody-positive JDM
    Baluta, Sarah
    Stojkic, Ivana
    Driest, Kyla
    Schutt, Christina
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [47] Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy
    Kadoya, Masato
    Hida, Ayumi
    Maeda, Meiko Hashimoto
    Taira, Kenichiro
    Ikenaga, Chiseko
    Uchio, Naohiro
    Kubota, Akatsuki
    Kaida, Kenichi
    Miwa, Yusuke
    Kurasawa, Kazuhiro
    Shimada, Hiroyuki
    Sonoo, Masahiro
    Chiba, Atsuro
    Shiio, Yasushi
    Uesaka, Yoshikazu
    Sakurai, Yasuhisa
    Izumi, Toru
    Inoue, Manami
    Kwak, Shin
    Tsuji, Shoji
    Shimizu, Jun
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (06):
  • [48] Myopathological features of cancer-free myositis with anti-TIF1-γ-Ab positive
    Taira, Kenichiro
    Uchio, Naohiro
    Unuma, Atsushi
    Kadoya, Masato
    Ikenaga, Chiseko
    Kubota, Akatsuki
    Shimizu, Jun
    Toda, Tatsushi
    BRAIN PATHOLOGY, 2019, 29 : 32 - 32
  • [49] Clinical Features Associated with the Presence of anti-SSA/Ro60 Antibodies in anti-Jo-1 Antibody-positive Myositis
    Yamaguchi, Koichi
    Tang, Qi
    Poland, Paul
    Aggarwal, Rohit
    Oddis, Chester
    Ascherman, Dana
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 300 - 302
  • [50] Clinical features of anti-SAE1 antibody-positive myositis and interstitial lung disease: a multicenter, retrospective study in Taiwan
    Hsiao, Chao-Yang
    Tseng, Shu-Chi
    Hsu, Chung-Yuan
    Chiu, Li-Chung
    Su, Li-Jen
    Chan, Tien-Ming
    FRONTIERS IN IMMUNOLOGY, 2024, 15